Document is current
Any future updates will be listed below
-
Authors
Nakahara, Takeshi
Noto, Shinichi
Matsukawa, Miyuki
Takeda, Hiroe
Zhang, Yilong
Kondo, Tomohiro https://orcid.org/0009-0002-7275-359X
-
Funding
Funding for this research was provided by:
Otsuka Pharmaceutical Co., Ltd.
- License Information
-
More Information
Article History
Received: 1 August 2024
Accepted: 21 October 2024
First Online: 1 November 2024
Declarations
:
: Takeshi Nakahara has received consulting fees and/or speaker honoraria from Mitsubishi Tanabe Pharma Corporation, Taiho Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., Maruho Co., Ltd., Sanofi K.K, AbbVie GK, Eli Lilly Japan K.K., Sun Pharma Japan Ltd., and Otsuka Pharmaceutical Co., Ltd. Shinichi Noto received speaker honoraria from Otsuka Pharmaceutical Co., Ltd. Miyuki Matsukawa, Hiroe Takeda, Yilong Zhang, and Tomohiro Kondo are employees of Otsuka Pharmaceutical Co., Ltd. The funders provided only the funds necessary for this study, and there were no factors that significantly influenced the results. The study was started after obtaining approval through the Otsuka Pharmaceutical theme evaluation.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
